Intellia Therapeutics Aktie
6,58
EUR
-0,02
EUR
-0,33
%
7,51
USD
+0,10
USD
+1,35
%
Werbung
Intellia Therapeutics Aktie Analyse
02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung